Duch Ditto secures €7.6 million for AI-powered summaries of medical appointments from the patient's perspective.
Ditto, a health-tech company based in Amsterdam that creates AI-generated summaries of medical appointments for patients, has secured €7.6 million in funding, the company announced on Monday.
The funding round was led by Heal Capital and included participation from Rubio Impact Ventures, along with previous investor Chris Oomen, chair of Optiverder. This investment will aid in expanding operations into Germany, the UK, and Spain this year, as well as in the ongoing development of the company's consumer product.
Ditto was established by CEO Tobias Lensing and co-founders Bart Voorn and Merlijn van Breugel after Lensing accompanied a friend with stage-4 bile duct cancer to an oncology appointment and realized they left with significantly different understandings of the doctor's communication.
The company notes that patients typically recall only 20% to 40% of what is discussed during medical consultations.
Their product is a mobile app that records consultations with the patient's consent, generating a structured, easy-to-understand summary for the patient to revisit, share with family members, and utilize for future appointments.
This approach contrasts with the predominant trend in healthcare AI, which has focused on tools for clinicians for tasks like note-taking and chart completion. Ditto contends that the more impactful opportunity lies in addressing patient needs.
Launching in the Netherlands with the backing of the national Patient Federation, Ditto aimed for 10,000 downloads within six months but achieved this milestone in less than two weeks, now nearing 100,000 users in the Netherlands with a 4.7-star rating on both the App Store and Google Play. The company also recently won the Dutch Healthcare Innovation Award.
In the announcement, Lensing emphasized the strategic nature of their design choice. "Almost every AI company in healthcare today is building for doctors," he remarked. "All meaningful. But nobody is focusing on the individual on the other side of the desk: the one who has to cope with the diagnosis, remember the directions, and communicate it to their family that evening."
He described the platform as a pivotal factor in improving patient outcomes: "The most effective medicine isn’t a drug. It’s a patient who understands what’s happening."
Ditto is offered free of charge to patients. The company is financed through collaborations with insurers, patient organizations, and healthcare institutions, based on the idea that a summary which informs a patient can also minimize follow-up calls, repetitive explanations, and missed appointments from the clinician's perspective.
The company plans to deepen its involvement in the patient journey, assisting users in preparing for upcoming appointments based on their consultation history instead of merely summarizing past ones.
Heal Capital is known as one of Europe's most active health-tech investors, while Rubio Impact Ventures has an impact-focused mission aimed at communities the press release describes as those "the system already neglects."
The company did not reveal its post-money valuation or revenue figures. Ditto operates in accordance with the EU AI Act and provides information on its compliance status on its website.
Otros artículos
Duch Ditto secures €7.6 million for AI-powered summaries of medical appointments from the patient's perspective.
Dutch health-tech company Ditto has secured €7.6 million in funding, led by Heal Capital, to broaden the reach of its patient-focused AI consultation-summary app into Germany, the UK, and Spain.
